Related Experiment Video
Updated: Feb 1, 2026

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
Published on: June 2, 2019
Protein structure and coupled solvent dynamics in α-synuclein fibrils under controlled confinement.
Katie Lynn Whitcomb1, Kurt Warncke1
1Department of Physics, Emory University, Atlanta, Georgia 30322.
Parkinson's disease protein alpha-synuclein fibrils exhibit dynamic disorder. Confinement and temperature changes reveal protein collapse and folding, offering insights for drug development targeting these fibrils.
Area of Science:
- Biophysics
- Neuroscience
- Structural Biology
Background:
- Alpha-synuclein fibril formation is central to Parkinson's disease pathogenesis.
- The dynamic disordered regions of alpha-synuclein fibrils remain poorly understood.
- Understanding these regions is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To characterize the physical and mechanical properties of dynamically disordered domains in alpha-synuclein fibrils.
- To investigate the effects of in vivo confinement and small-molecule interactions on these domains.
- To establish a platform for assessing drugs targeting alpha-synuclein fibrils.
Main Methods:
- Electron paramagnetic resonance (EPR) spectroscopy using the spin probe TEMPOL.
- Temperature-controlled, ice boundary confinement.
- Analysis of spin probe rotational correlation times and van't Hoff/Arrhenius kinetics.
Main Results:
- Two distinct motional components were identified, corresponding to disordered protein termini and hydration layers.
- Protein compaction and folding transitions were observed with decreasing temperature and increasing confinement.
- Hysteresis and bistability in structural transitions were revealed, suggesting potential drug interaction sites.
- Dimethyl sulfoxide demonstrated confinement relief effects consistent with the proposed model.
Conclusions:
- The study elucidates the dynamic behavior of disordered regions in alpha-synuclein fibrils under confinement.
- Compaction transitions are accessible under physiological conditions, providing therapeutic targets.
- The developed system offers a robust platform for evaluating alpha-synuclein fibril-targeted drugs.
More Related Videos
09:32Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils
Published on: April 13, 2017
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
Related Concept Videos
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
G-protein Coupled Receptors
Solvents
A...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...